Biogen’s lack of insider buying and reduced R&D spending raise concerns, but its future growth prospects remain. Find out why ...

Calumet Specialty Products appears deeply undervalued with strong EBITDA momentum and short pressure building. Learn why CLMT ...

J&J faces several headwinds at the start of the year, including patent expiry, talc litigation, and, now, tariffs.

Former Reagan economic advisor Art Laffer said Tuesday both the world and U.S. would see benefit from President Donald ...

Despite federal efforts to expand broadband and boost rural healthcare, more than 200 counties still lack reliable internet ...

Greetings, and welcome to the Zions Bancorp Q1 2025 Earnings Conference Call. At this time, all participants are in a ...

A White House statement released after Trump announced the policy said existing tariffs on Canada 'remain in effect' — ...

The developments came as China has struck a publicly defiant tone and Trump sowed confusion by claiming that he had spoken ...

In case you don’t know, the BOJ (Bank of Japan) owns around 7% of the Japanese stock market and about 70% of the ETFs in circulation. In other words, the BOJ is the Fed on steroids. All I can say with ...

American imports from Canada and Mexico that are compliant with United States-Mexico-Canada Agreement (USMCA) will be given exemption from the broader tariffs and individual reciprocal tariffs. USMC ...

Q4 2024 Earnings Call Transcript March 31, 2025 Rani Therapeutics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $-0.24. Operator: Welcome to the Rani ...